Real life stories

Inspiring stories from people living with diabetes.

Featured videos

Alexandra's story

Play button Alexandra's story

Managing diabetes can take a lot of effort, but thanks to the MiniMed™ 780G system, our newest #MedtronicPartner, Alexandra, can now sleep throughout the night with stable sugar levels and wake up ready to take on the day.Φ

Sarah's story

Play button Sarah's story

Sarah is an avid rugby player who loves to cook and play with her cute pup, Mack! Check out her experience using the InPen smart insulin pen with the Guardian Connect CGM to get real-time diabetes data.Φ

Grace's story

Play button Grace’s story

Grace was originally misdiagnosed with type 2 diabetes. Today, she’s making sure her voice is heard to bring more awareness to type 1 diabetes and Asian American culture.Φ

Terry's story

Play button Terry’s story

Terry has been managing his diabetes with the MiniMed™ 780G system and loves how intuitive and user-friendly it is. With the MiniMed™ 780G system, Terry can enjoy more freedom and flexibility in his daily life.Φ

Josephine and Henry’s story

Play button Josephine and Henry’s story

The MiniMed™ 780G system helps Josephine and Henry manage their diabetes with ease and confidence, while their parents love the peace of mind the system provides.Φ

Mattie’s story

Play button Mattie’s story

Mattie uses the InPen™ smart insulin pen to help manage her diabetes. She uses the calculator, which recommends the right insulin dose for each meal. Hear her story.Φ

Allison's story

Play button Allison's story

Allison loves to be active outside. With the MiniMed™ 780G system, she has more freedom to do what she loves and her parents can worry less.Φ

April's story

Play button April's story

April loves how the MiniMed™ 780G system makes the complexity of food management easier. With its advanced SmartGuard™ technology, the system helps April in managing her sugar levels even when she eats foods that are harder to manage.

Aaron's story

Play button Aaron's story

Aaron was diagnosed with type 1 diabetes at two years old and has made sure his diabetes doesn’t hold him back! Hear his story.Φ

Lauren's story

Play button Lauren’s story

Lauren Cox is the first ever WNBA player living with type 1 diabetes. We’re thrilled to be partnering with her to bring more awareness to diabetes and Medtronic technologies! Hear her story.Φ

Matt’s story

Play button Matt’s story

Matt loves that SmartGuard™ technology has his back if he miscalculates a carb count.* The MiniMed™ 780G system lets him live his life without diabetes getting in the way.Φ


Linda's story


Running towards her goals: meet #MedtronicChampion LindaΦ

Jean-Sebastien's story

Using his insulin pump to his advantage - Jean-Sebastien's story

Using his insulin pump to his advantage: meet #MedtronicChampion Jean-SebastienΦ

Dalton's story

Overcoming obstacles to achieve his goals - Dalton' story

Overcoming obstacles to achieve his goals: meet #MedtronicChampion DaltonΦ

Daniela's story

From fear to flourish - Daniela' story

From fear to flourish: meet #MedtronicChampion DanielaΦ

Phyllis's story

How diabetes therapies have changed - Phyllis' story

How diabetes therapies have changedΦ

Katie's story

I knew I could take this on for my child - Katie's story

I knew I could take this on for my childΦ

Jamie's story

5 lessons on starting insulin pump therapy - Jamie's story

5 lessons on starting insulin pump therapyΦ

Get It Back stories

Our customers are getting it back with the MiniMed™ 780G system. See what they have to say.

Watch stories

Talk to a diabetes therapy consultant

For more information about our solutions that are currently available, complete the form or call 1-888-350-5440 (M-F 9 a.m.–6 p.m. CT).


How can we communicate with you?

* Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
Individual results may vary.
Φ The patient testimonial above relates an account of an individual’s response to treatment. The account is genuine, typical and documented. However, this patient’s response does not provide any indication, guide, warranty or guarantee as to the response other people may have to the treatment. The response other individuals have to the treatment could be different. Responses to the treatment can and do vary. Not every response is the same. Please talk to your doctor about your condition and the risks and benefits of these technologies.

Some of our Medtronic Champions were compensated previously for spending the day with us and allowing us to photograph/videotape them. Blogs were not included in that compensation. Their thoughts and opinions are their own. Individual results may vary.

Jamie is an employee of Medtronic. Her thoughts and opinions are her own.

Important safety information: MiniMed 780G system with SmartGuard technology with Guardian 4 sensor

The MiniMed 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed 780G system consists of the following devices: MiniMed 780G insulin pump, the Guardian 4 transmitter, the Guardian 4 sensor, One-press serter, the Accu-Chek Guide Link blood glucose meter, and the Accu-Chek Guide test strips. The system requires a prescription from a healthcare professional.

The Guardian 4 sensor is intended for use with the MiniMed 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian 4 sensor is indicated for up to seven days of continuous use.

The Guardian 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian 4 sensor. The Guardian 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

WARNING: Do not use the SmartGuard feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard feature.

WARNING: Do not use the MiniMed 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult and the appropriate user guide at

Important Safety Information: InPen
The InPen is a home- use reusable pen injector for single- patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self- injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient- specific criteria and targets. The InPen requires a prescription. For additional product and safety information, please consult the Instructions for Use and

Important Safety Information: Guardian Connect CGM System
The Guardian Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at and important safety information.